Dabigatran vs Nivolumab

Dabigatran vs Nivolumab: Overview

This comparison examines the pharmacological differences between Dabigatran and Nivolumab.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3.

Molecular Weight: Dabigatran — 471.5100 g/mol.

Type: Dabigatran — Small molecule; Nivolumab — Antibody.